Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
Journal of Biochemistry|December 8, 2021
Patient-derived gene and protein expression signatures of NGLY1 deficiencyBenedikt Rauscher, William F Mueller, Sandra Clauder-Münster, et al.Nature Methods|October 30, 2019
Biological plasticity rescues target activity in CRISPR knock outsArne H Smits, Frederik Ziebell, Gerard Joberty, et al.Nature Biotechnology|August 28, 2007
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsMarcus Bantscheff, Dirk Eberhard, Yann Abraham, et al.ACS Chemical Biology|May 20, 2016
Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical ProteomicsGérard Joberty, Markus Boesche, Jack A Brown, et al.ACS Infectious Diseases|November 3, 2022
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in Mycobacterium tuberculosisVinayak Singh, Anna E Grzegorzewicz, Stephen Fienberg, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 27, 2023
Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiencyLaura Guantay, Cintia Garro, Sebastián Siri, et al.Nature Biotechnology|January 25, 2011
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesMarcus Bantscheff, Carsten Hopf, Mikhail M Savitski, et al.Nature Chemical Biology|May 1, 2012
A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiationGiovanna Bergamini, Kathryn Bell, Satoko Shimamura, et al.Nature Microbiology|August 31, 2016
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteriaJonathan A G Cox, Katherine A Abrahams, Carlos Alemparte, et al.Journal of Medicinal Chemistry|April 10, 2015
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 InhibitionNatalie H Theodoulou, Paul Bamborough, Andrew J Bannister, et al.Pageof 8